We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Hospital Planned for Limmat Valley

By HospiMedica International staff writers
Posted on 22 Jun 2015
The Spital Limmattal (Schlieren, Switzerland) hospital group will build a new hospital in the Swiss Limmat Valley.

The new hospital will include an eight-story building with 50,000 m² of floor space that will accommodate 200 beds, each with its own bathroom. More...
Among the facilities planned are five operating theatres, an accident and emergency department with a 12 bed capacity, and a maternity unit. Technical facilities will include a car park situated on two basement levels, a restaurant, administrative offices, laboratories, and X-ray facilities. Modern electrical and ventilation systems will be designed to minimize the risk of infection.

Built at an investment of EUR 175 million, the hospital will serve the residents of Schlieren, a town that is part of the Zurich metropolitan area. The hospital will be built next to the existing Spital Limmattal hospital, which is over 40 years old. Both the buildings and the infrastructure (ventilation, water, gas, and power systems) of the existing hospital are outdated, and no longer meet the needs and requirements of the 10,500 inpatients and 59,000 outpatients that attend the hospital yearly.

Losinger Marazzi (Köniz, Switzerland) , a subsidiary of Bouygues Construction (Saint-Quentin-en-Yvelines, France), will design and build the new hospital, which is the first in Switzerland to be developed with the use of building information modeling (BIM), a process that involves the generation and management of digital representations of physical and functional characteristics, which can then be exchanged or networked to support design decisions. The company will begin the fitting out phase of the project in the third quarter of 2016, and the facility is expected to become operational in 2018.

“This contract illustrates our development in the healthcare sector in Switzerland, where investments of some EUR 20 billion are expected over the next 15 years,” said Pascal Minault, CEO of Bouygues Entreprises France-Europe. “Losinger Marazzi is benefiting from the expertise of the Bouygues Construction Group, which has completed dozens of hospital projects in recent years in France, the United Kingdom, Canada, and other countries.”

Related Links:

Spitalverband Limmattal
Losinger Marazzi
Bouygues Construction



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Endoscopy Display
E190
New
Trocar
TAN RoTaLock Trocar
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.